Inclusive
7078
Chordia Therapeutics
190A
Ecomott
3987
Cube
7112
Kufu Company Holdings
4376
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|
Total revenue | 54.69%14.37B | 0.24%9.29B | 85.81%9.27B | 4.99B |
Cost of revenue | 59.93%11.45B | -1.67%7.16B | 89.90%7.28B | 3.84B |
Gross profit | 37.03%2.91B | 7.24%2.13B | 72.19%1.98B | 1.15B |
Operating expense | 44.05%2.26B | 14.41%1.57B | 54.64%1.37B | 888.37M |
Operating profit | 17.10%649.16M | -8.95%554.36M | 131.45%608.82M | 263.05M |
Net non-operating interest income (expenses) | -13.91%-24.21M | -25.79%-21.26M | -95.24%-16.9M | -8.66M |
Non-operating interest income | 20.00%18K | -6.25%15K | 6.67%16K | --15K |
Non-operating interest expense | 13.91%24.23M | 25.76%21.27M | 95.09%16.92M | --8.67M |
Net investment income | 57.26%-12.36M | 23.24%-28.92M | 24.10%-37.68M | -49.64M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||
Gain(Loss) on derecognition of available-for-sale financial assets | -15.79M | 0 | -7.48M | |
Income from associates and other participating interests | 54.95M | 0 | ||
Special income (charges) | -105.54%-645K | 195.98%11.64M | -16.35%3.93M | 4.7M |
Less:Other special charges | -30.74%-15.22M | -195.98%-11.64M | 16.35%-3.93M | ---4.7M |
Less:Write off | --15.87M | --0 | ---- | ---- |
Other non-operating income (expenses) | 0.92%11.37M | -62.01%11.26M | 936.50%29.64M | 2.86M |
Income before tax | 25.69%662.47M | -10.33%527.08M | 186.97%587.82M | 204.84M |
Income tax | 22.10%214.93M | -11.35%176.03M | 211.09%198.58M | 63.83M |
Net income | 27.49%447.54M | -9.81%351.04M | 176.05%389.24M | 141.01M |
Net income continuous operations | 27.49%447.54M | -9.81%351.04M | 176.05%389.24M | --141.01M |
Noncontrolling interests | ||||
Net income attributable to the company | 27.49%447.54M | -9.81%351.04M | 176.05%389.24M | 141.01M |
Preferred stock dividends | ||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 27.49%447.54M | -9.81%351.04M | 176.05%389.24M | 141.01M |
Gross dividend payment | ||||
Basic earnings per share | 27.49%221.55 | -9.81%173.78 | 176.04%192.69 | 69.805 |
Diluted earnings per share | 27.49%221.55 | -9.81%173.78 | 176.04%192.69 | 69.805 |
Dividend per share | 10 | |||
Currency Unit | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |